Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 225-266-7 | CAS number: 4747-21-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study conducted according to GLP.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 008
- Report date:
- 2008
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Version / remarks:
- (2001)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
- Version / remarks:
- (2004)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.1100 (Acute Oral Toxicity)
- Version / remarks:
- (2002)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: Japan MAFF Testing Guideline of 12 Nosan No. 8147 as this in line with OECD 423
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
- Limit test:
- no
Test material
- Reference substance name:
- N-methylisopropylamine
- EC Number:
- 225-266-7
- EC Name:
- N-methylisopropylamine
- Cas Number:
- 4747-21-1
- Molecular formula:
- C4H11N
- IUPAC Name:
- methyl(propan-2-yl)amine
- Details on test material:
- - Name of test material (as cited in study report): N-Methylisopropylamine
- Physical state: liquid, yellowish
- Analytical purity: >99.9%
- Lot/batch No.: 8078/06/056
- Stability under test conditions: the stability of the test substance under storage conditions over the test period was guaranteed by the manufacturer, and the manufacturer holds this responsibility
- Storage condition of test material: room temperature, in the dark, under N2
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: RCC Ltd Laboratory Animal Services, CH-4414 Füllinsdorf, Switzerland
- Age at study initiation: 9 to 11 weeks
- Mean weight at study initiation: about 176 g
- Fasting period before study: at least 16 hours before administration
- Housing: single housing in Makrolon cage, type III
- Diet (e.g. ad libitum): VRF1(P); SDS Special Diets Services, Altrip, Germany), ad libitum
- Water (e.g. ad libitum): Tap water ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 – 24
- Humidity (%): 20 – 80
- Air changes (per hr): not specified
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- DOSAGE PREPARATION AND APPLICATION
For the high dose, the liquid test substance was administered undiluted at an application volume of 2.99 mL/kg bw.
For the lower doses, test substance preparations in bidistilled water were used and the application volume was 3 mL/kg bw. - Doses:
- 2000 (one test group), 300 (one test group), 50 mg/kg bw (two test groups)
- No. of animals per sex per dose:
- As suggested by the OECD guideline nulliparous and nonpregnant female animals were used for the test, because there is no indication that male animals are likely to be more sensitive to the acute effects of the test substance.
Three females per test group were used. - Control animals:
- no
- Details on study design:
- OBSERVATION PERIOD
Treatment was followed by an observation period of at least 21 days.
CLINICAL SIGNS AND MORTALITY
Observation for clinical signs was done several times on the day of administration and at least once each workday thereafter; check for any dead or moribund animal was made twice each workday and once on Saturdays, Sundays and on public holidays.
BODY WEIGHT
Individual body weights were recorded shortly before administration (day 0), weekly thereafter and on the last day of observation. Additionally, at day of death in animals that died or were sacrificed moribund starting with study day 2.
NECROPSY
At the end of the observation period the animals were sacrificed by CO2-inhalation and were subjected to gross pathology. No histological examinations were performed.
Examination of all animals that died before test ending was conducted as early as possible after death.
Results and discussion
Effect levels
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 50 - 300 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: All animals of the 2000 mg/kg bw group died within 1 hr post-treatment. One animal of the 300 mg/kg bw group died on day 2 and a further one was sacrificed in extremis on day 17 because of moribund state. All animals treated with 50 mg/kg bw survived.
- Mortality:
- All animals of the 2000 mg/kg bw group died within the first hour after administration. Thus, mortality at 2000 mg/kg bw was 100%.
One animal of the 300 mg/kg bw group was found dead on day 2 of observation whereas a further one needed to be sacrificed on day 17 because of moribund state. Thus, mortality at 300 mg/kg bw was about 70%.
All animals treated with 50 mg/kg bw survived. - Clinical signs:
- other: Because the animals in the 2000 mg/kg bw group died immediately after administration, no clinical signs and findings were observed. Clinical signs seen in the 300 mg/kg bw group included impaired general state, dyspnoea, piloerection, red to orange-red di
- Gross pathology:
- Necropsy of animals that died:
Gross pathological examination of animals that died during the experiment (3/3 in the 2000 mg/kg bw group and 1/3 in the 300 mg/kg bw group) revealed dark red to brown discoloration of lung, black discoloration of heart, clotted blood in the thorax, petechial bleeding in the stomach and dark discoloration of liver, stomach, spleen, heart and small intestine.
Necropsy of animals sacrificed in extremis or at the end of the observation period:
Gross pathological examination of animals that were sacrificed revealed no abnormalities (2/3 in the 300 mg/kg bw group and 6/6 in the 50 mg/kg bw group).
Any other information on results incl. tables
N-Methylisopropylamine (MIPA): Acute oral toxicity test, individual body weight changes
Dose |
2000 mg/ kg bw |
300 mg/kg bw |
||||||
|
Individual weights (g) |
Mean weight (g) |
Individual weights (g) |
Mean weight (g) |
||||
Animal |
1 |
2 |
3 |
1 |
2 |
3 |
||
Day 0 |
176 |
179 |
178 |
178 |
171 |
175 |
176 |
174 |
Day 2 |
n.a. |
n.a. |
n.a. |
n.a. |
150* |
n.r. |
n.r. |
n.r |
Day 7 |
n.a. |
n.a. |
n.a. |
n.a. |
n.a. |
174 |
161 |
168 |
Day 14 |
n.a. |
n.a. |
n.a. |
n.a. |
n.a. |
197 |
157 |
177 |
Day 17 |
n.a. |
n.a. |
n.a. |
n.a. |
n.a. |
n.r. |
139** |
n.r. |
Day 21 |
n.a. |
n.a. |
n.a. |
n.a. |
n.a. |
214 |
n.a. |
214 |
Dose |
50 mg/ kg bw |
50 mg/kg bw |
||||||
|
Individual weights (g) |
Mean weight (g) |
Individual weights (g) |
Mean weight (g) |
||||
Animal |
1 |
2 |
3 |
1 |
2 |
3 |
||
Day 0 |
206 |
206 |
190 |
201 |
196 |
194 |
199 |
196 |
Day 7 |
226 |
226 |
210 |
221 |
218 |
215 |
218 |
217 |
Day 14 |
243 |
242 |
217 |
234 |
229 |
225 |
227 |
227 |
Day 17 |
n.r. |
n.r. |
n.r. |
n.r. |
n.r. |
n.r. |
n.r. |
n.r. |
Day 21 |
n.r. |
n.r. |
n.r. |
n.r. |
n.r. |
n.r. |
n.r. |
n.r. |
n.a., not applicable since animal died; n.r., not recorded; *, animal died; **,animal was sacrificed in extremis because of moribund state |
Applicant's summary and conclusion
- Interpretation of results:
- Category 3 based on GHS criteria
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.